{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T02:24:33Z","timestamp":1789179873102,"version":"build-2803163510"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"German Research Council"},{"name":"Centre of Nanoscale Microscopy and Physiology of the Brain"},{"name":"European Community","award":["E!7900: ESTAR13113\/19\/NCBR\/2014"],"award-info":[{"award-number":["E!7900: ESTAR13113\/19\/NCBR\/2014"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.expneurol.2018.07.017","type":"journal-article","created":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T12:20:44Z","timestamp":1533126044000},"page":"79-90","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Therapeutic efficacy of regulable GDNF expression for Huntington's and Parkinson's disease by a high-induction, background-free \u201cGeneSwitch\u201d vector"],"prefix":"10.1016","volume":"309","author":[{"given":"Shi","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Tereshchenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Zimmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Vachey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Pythoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Rey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolanda","family":"Liefhebber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anupam","family":"Raina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Streit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Mazur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"B\u00e4hr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavlina","family":"Konstantinova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"D\u00e9glon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"K\u00fcgler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2018.07.017_bb0005","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0361-9230(01)00775-4","article-title":"Neuroprotection by neurotrophins and GDNF family members in the excitotoxic model of Huntington's disease","volume":"57","author":"Alberch","year":"2002","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.expneurol.2018.07.017_bb0010","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.expneurol.2006.11.014","article-title":"Controlled delivery of glial cell line-derived neurotrophic factor by a single tetracycline-inducible AAV vector","volume":"204","author":"Chtarto","year":"2007","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2018.07.017_bb0015","doi-asserted-by":"crossref","first-page":"16027","DOI":"10.1038\/mtm.2016.27","article-title":"A regulatable AAV vector mediating GDNF biological effects at clinically-approved sub-antimicrobial doxycycline doses","volume":"5","author":"Chtarto","year":"2016","journal-title":"Mol. Ther. Methods. Clin. Dev."},{"key":"10.1016\/j.expneurol.2018.07.017_bb0020","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/WCO.0000000000000384","article-title":"Clinical subtypes and genetic heterogeneity: of lumping and splitting in Parkinson disease","volume":"29","author":"von Coelln","year":"2016","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.expneurol.2018.07.017_bb0025","doi-asserted-by":"crossref","first-page":"156","DOI":"10.2174\/1566523216666160524144041","article-title":"Tet-on systems for doxycycline-inducible gene expression","volume":"16","author":"Das","year":"2016","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.expneurol.2018.07.017_bb0030","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1182\/blood-2002-09-2889","article-title":"Sex significantly influences transduction of murine liver by recombinant adeno-associated viral vectors through an androgen-dependent pathway","volume":"102","author":"Davidoff","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.expneurol.2018.07.017_bb0035","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.expneurol.2010.03.005","article-title":"Ex vivo delivery of GDNF maintains motor function and prevents neuronal loss in a transgenic mouse model of Huntington's disease","volume":"224","author":"Ebert","year":"2010","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2018.07.017_bb0040","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1002\/j.1460-2075.1993.tb05909.x","article-title":"Poly(a) signals and transcriptional pause sites combine to prevent interference between RNA polymerase II promoters","volume":"12","author":"Eggermont","year":"1993","journal-title":"EMBO J."},{"key":"10.1016\/j.expneurol.2018.07.017_bb0045","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3758\/BRM.41.4.1149","article-title":"Statistical power analyses using G\u2217Power 3.1: tests for correlation and regression analyses","volume":"41","author":"Faul","year":"2009","journal-title":"Behav. Res. Methods"},{"key":"10.1016\/j.expneurol.2018.07.017_bb0050","doi-asserted-by":"crossref","first-page":"11605","DOI":"10.1128\/JVI.76.22.11605-11611.2002","article-title":"Lack of an immune response against the tetracycline-dependent transactivator correlates with long-term doxycycline-regulated transgene expression in nonhuman primates after intramuscular injection of recombinant adeno-associated virus","volume":"76","author":"Favre","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.expneurol.2018.07.017_bb0055","first-page":"33","article-title":"Mifepristone (RU-486) treatment for depression and psychosis: a review of the therapeutic implications","volume":"2","author":"Gallagher","year":"2006","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.expneurol.2018.07.017_bb0060","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1089\/hum.2004.15.934","article-title":"Regulated delivery of glial cell line-derived neurotrophic factor into rat striatum, using a tetracycline-dependent lentiviral vector","volume":"15","author":"Georgievska","year":"2004","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.expneurol.2018.07.017_bb0065","doi-asserted-by":"crossref","first-page":"6182","DOI":"10.1523\/JNEUROSCI.0857-08.2008","article-title":"Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice","volume":"28","author":"Gray","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2018.07.017_bb0070","doi-asserted-by":"crossref","first-page":"861","DOI":"10.3171\/jns.1991.74.6.0861","article-title":"Treatment of unresectable meningiomas with the antiprogesterone agent mifepristone","volume":"74","author":"Grunberg","year":"1991","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.expneurol.2018.07.017_bb0075","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1002\/mds.25159","article-title":"Striatal neuronal loss correlates with clinical motor impairment in Huntington's disease","volume":"27","author":"Guo","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2018.07.017_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0027728","article-title":"Evaluation of an AAV2-based rapamycin-regulated glial cell line-derived neurotrophic factor (GDNF) expression vector system","volume":"6","author":"Hadaczek","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2018.07.017_bb0085","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/0006-2952(96)00357-7","article-title":"Identification of CYP3A4 as the principal enzyme catalyzing mifepristone (RU 486) oxidation in human liver microsomes","volume":"52","author":"Jang","year":"1996","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.expneurol.2018.07.017_bb0090","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0015-0282(16)58022-4","article-title":"Treatment of endometriosis with the antiprogesterone mifepristone (RU486)","volume":"65","author":"Kettel","year":"1996","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.expneurol.2018.07.017_bb0095","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1093\/brain\/awt192","article-title":"Disease duration and the integrity of the nigrostriatal system in Parkinson's disease","volume":"136","author":"Kordower","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2018.07.017_bb0100","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/978-1-4939-3271-9_6","article-title":"Tissue-specific promoters in the CNS","volume":"1382","author":"K\u00fcgler","year":"2016","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.expneurol.2018.07.017_bb0105","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0042-6822(03)00162-4","article-title":"Differential transgene expression in brain cells in vivo and in vitro from AAV-2 vectors with small transcriptional control units","volume":"311","author":"K\u00fcgler","year":"2003","journal-title":"Virology"},{"key":"10.1016\/j.expneurol.2018.07.017_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0102538","article-title":"Transgene regulation using the tetracycline-inducible TetR-KRAB system after AAV-mediated gene transfer in rodents and nonhuman primates","volume":"9","author":"Le Guiner","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2018.07.017_bb0115","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2013.35","article-title":"Adeno-associated virus-mediated, Mifepristone-regulated Transgene Expression in the Brain","volume":"2","author":"Maddalena","year":"2013","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.expneurol.2018.07.017_bb0120","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1038\/mt.2013.95","article-title":"Mouse gender influences brain transduction by intravascularly administered AAV9","volume":"21","author":"Maguire","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.expneurol.2018.07.017_bb0125","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1038\/mt.2009.45","article-title":"Nigrostriatal rAAV-mediated GDNF overexpression induces robust weight loss in a rat model of age-related obesity","volume":"17","author":"Manfredsson","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.expneurol.2018.07.017_bb0130","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.nbd.2012.03.001","article-title":"Regulated protein expression for in vivo gene therapy for neurological disorders: progress, strategies, and issues","volume":"48","author":"Manfredsson","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2018.07.017_bb0135","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0014-4886(03)00044-X","article-title":"Structural and functional neuroprotection in a rat model of Huntington's disease by viral gene transfer of GDNF","volume":"181","author":"McBride","year":"2003","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2018.07.017_bb0140","doi-asserted-by":"crossref","first-page":"9345","DOI":"10.1073\/pnas.0508875103","article-title":"Viral delivery of glial cell line-derived neurotrophic factor improves behavior and protects striatal neurons in a mouse model of Huntington's disease","volume":"103","author":"McBride","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2018.07.017_bb0145","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0015-0282(16)57678-X","article-title":"Regression of uterine leiomyomata to the antiprogesterone RU486: dose-response effect","volume":"64","author":"Murphy","year":"1995","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.expneurol.2018.07.017_bb0150","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1200\/JCO.1996.14.10.2709","article-title":"Phase II study of the progesterone antagonist mifepristone in patients with untreated metastatic breast carcinoma: a National Cancer Institute of Canada Clinical Trials Group study","volume":"14","author":"Perrault","year":"1996","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.expneurol.2018.07.017_bb0155","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.expneurol.2004.12.009","article-title":"Lentiviral gene delivery of GDNF into the striatum of R6\/2 Huntington mice fails to attenuate behavioral and neuropathological changes","volume":"193","author":"Popovic","year":"2005","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2018.07.017_bb0160","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1093\/hmg\/ddq026","article-title":"Full-length huntingtin levels modulate body weight by influencing insulin-like growth factor 1 expression","volume":"19","author":"Pouladi","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2018.07.017_bb0165","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1038\/mt.2013.169","article-title":"Functional neuroprotection and efficient regulation of GDNF using destabilizing domains in a rodent model of Parkinson's disease","volume":"21","author":"Quintino","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.expneurol.2018.07.017_bb0170","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","article-title":"Dose translation from animal to human studies revisited","volume":"22","author":"Reagan-Shaw","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.expneurol.2018.07.017_bb0175","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1182\/blood-2004-06-2501","article-title":"Long-term pharmacologically regulated expression of erythropoietin in primates following AAV-mediated gene transfer","volume":"105","author":"Rivera","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.expneurol.2018.07.017_bb0180","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0306-4522(94)90605-X","article-title":"Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat","volume":"59","author":"Sauer","year":"1994","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2018.07.017_bb0185","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.contraception.2006.03.016","article-title":"Mifepristone and misoprostol sequential regimen side effects, complications and safety","volume":"74","author":"Sitruk-Ware","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.expneurol.2018.07.017_bb0190","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0010-7824(03)00171-9","article-title":"Pharmacological properties of mifepristone: toxicology and safety in animal and human studies","volume":"68","author":"Sitruk-Ware","year":"2003","journal-title":"Contraception"},{"key":"10.1016\/j.expneurol.2018.07.017_bb0195","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.ymthe.2005.12.001","article-title":"Long-term doxycycline-regulated transgene expression in the retina of nonhuman primates following subretinal injection of recombinant AAV vectors","volume":"13","author":"Stieger","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.expneurol.2018.07.017_bb0200","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1089\/hum.2009.103","article-title":"Safety evaluation of AAV2-GDNF gene transfer into the dopaminergic nigrostriatal pathway in aged and parkinsonian rhesus monkeys","volume":"20","author":"Su","year":"2009","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.expneurol.2018.07.017_bb0205","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.omtn.2017.03.009","article-title":"A MicroRNA124 target sequence restores astrocyte specificity of gfaABC1D-driven transgene expression in AAV-mediated gene transfer","volume":"8","author":"Taschenberger","year":"2017","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.expneurol.2018.07.017_bb0210","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.nbd.2014.01.009","article-title":"Pharmacologically controlled, discontinuous GDNF gene therapy restores motor function in a rat model of Parkinson's disease","volume":"65","author":"Tereshchenko","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2018.07.017_bb0215","doi-asserted-by":"crossref","first-page":"809","DOI":"10.2174\/1381612822666161208120422","article-title":"Role of neurotrophic factors in Parkinson's disease","volume":"23","author":"Tome","year":"2017","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.expneurol.2018.07.017_bb0220","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1128\/JVI.80.4.1874-1885.2006","article-title":"Scalable generation of high-titer recombinant adeno-associated virus type 5 in insect cells","volume":"80","author":"Urabe","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.expneurol.2018.07.017_bb0225","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S1054-3589(08)60116-7","article-title":"An antiprogestin regulable gene switch for induction of gene expression in vivo","volume":"47","author":"Wang","year":"2000","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.expneurol.2018.07.017_bb0230","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/jgm.1377","article-title":"Reversible neurochemical changes mediated by delayed intrastriatal glial cell line-derived neurotrophic factor gene delivery in a partial Parkinson's disease rat model","volume":"11","author":"Yang","year":"2009","journal-title":"J. Gene Med."},{"key":"10.1016\/j.expneurol.2018.07.017_bb0235","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0076-6879(02)46076-4","article-title":"Ligand-inducible transgene regulation for gene therapy","volume":"346","author":"Ye","year":"2002","journal-title":"Methods Enzymol."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488618302899?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488618302899?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T05:50:14Z","timestamp":1762149014000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488618302899"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":47,"alternative-id":["S0014488618302899"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2018.07.017","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic efficacy of regulable GDNF expression for Huntington's and Parkinson's disease by a high-induction, background-free \u201cGeneSwitch\u201d vector","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2018.07.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}